- Home
- CLBK vs WGSWW Comparison
CLBK vs WGSWW Comparison
Compare CLBK & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBK
- WGSWW
- Stock Information
- Founded
- CLBK 1927
- WGSWW 2017
- Country
- CLBK United States
- WGSWW United States
- Employees
- CLBK N/A
- WGSWW 1000
- Industry
- CLBK Savings Institutions
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- CLBK Finance
- WGSWW Technology
- Exchange
- CLBK Nasdaq
- WGSWW Nasdaq
- Market Cap
- CLBK N/A
- WGSWW N/A
- IPO Year
- CLBK N/A
- WGSWW N/A
- Fundamental
- Price
- CLBK $14.00
- WGSWW $0.09
- Analyst Decision
- CLBK Hold
- WGSWW
- Analyst Count
- CLBK 1
- WGSWW 0
- Target Price
- CLBK $16.00
- WGSWW N/A
- AVG Volume (30 Days)
- CLBK 108.4K
- WGSWW 36.6K
- Earning Date
- CLBK 07-30-2025
- WGSWW 02-18-2025
- Dividend Yield
- CLBK N/A
- WGSWW N/A
- EPS Growth
- CLBK N/A
- WGSWW N/A
- EPS
- CLBK 0.06
- WGSWW N/A
- Revenue
- CLBK $187,256,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- CLBK $31.86
- WGSWW N/A
- Revenue Next Year
- CLBK $13.37
- WGSWW N/A
- P/E Ratio
- CLBK $231.05
- WGSWW N/A
- Revenue Growth
- CLBK N/A
- WGSWW 50.79
- 52 Week Low
- CLBK $12.64
- WGSWW $0.17
- 52 Week High
- CLBK $19.28
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- CLBK 41.58
- WGSWW N/A
- Support Level
- CLBK $13.89
- WGSWW N/A
- Resistance Level
- CLBK $14.68
- WGSWW N/A
- Average True Range (ATR)
- CLBK 0.46
- WGSWW 0.00
- MACD
- CLBK -0.09
- WGSWW 0.00
- Stochastic Oscillator
- CLBK 8.07
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.